Teva Pharmaceuticals - Wikipedia
Teva Pharmaceuticals Slashing 25% of Workforce, Suspending Dividend
Drugmaker Teva does not see big impact on business from Israel-Hamas war | Reuters
Teva hopes Sanofi collaboration will lead to blockbuster IBD drug | Reuters
Teva, AbbVie finalize $6.6 billion U.S. opioid settlements | Reuters
UK court backs Teva rival to AstraZeneca lung drug | Reuters
Teva and Eli Lilly scrap over migraine drug rights — MedWatch
CVS Picks Migraine Drugs by Teva, Eli Lilly, Snubs Amgen, Reuters Reports | Ctech
California judge rules for Israeli Teva in major opioid lawsuit - The Jerusalem Post
Politicians can decry Teva layoffs, but why did they give billions in tax breaks? - Israel News - The Jerusalem Post
Teva expects to start paying U.S. opioid settlement in 2023: CEO | Business Insurance
A Drug Company Wagers the U.S. Won't Dare Charge It With Crimes - The New York Times
Teva reaches proposed $4.35 billion settlement of US opioid lawsuits | CNN Business
Exclusive: Teva poised to raise its stake in Mylan - sources
GSK's $235 million verdict revived against Teva, again | Reuters
Teva rejects Israeli PM's request to keep Jerusalem plant open | Reuters
/cloudfront-us-east-2.images.arcpublishing.com/reuters/NTZR6T726RLT7GRNRNBROU2NCQ.jpg "US judge overturns Eli Lilly's $176.5 million loss in Teva patent case | Reuters")
US judge overturns Eli Lilly's $176.5 million loss in Teva patent case | Reuters
Teva's $420mn investor settlement to be mostly covered by insurers | The Insurer
Drug-maker Teva fueled opioid addiction in NY, jury finds | Business Insurance
Teva to Acquire Mexico's Rimsa for $2.3 Billion - WSJ
Teva expects sales injection from U.S. EpiPen market | Reuters
Teva Pharmaceutical meets forecasts, but 2023 outlook disappoints | Reuters
Teva Pharma shares sink as sales forecast disappoints market | Reuters
Teva Pharma to raise $20 billion to $25 billion in bond sale next week: report | Reuters
Teva Pharmaceutical Is in Recovery - WSJ
Teva To Start Nationwide Settlement Of Opioid Lawsuits From Next Year: Report
Walgreens, Teva face San Francisco trial over opioid epidemic | Business Insurance
Teva Pharmaceutical Industries Ltd | Reuters
